370 Tumor-wide neoantigen-specific T-cells infiltrating mutant IDH1 low-grade gliomas and persisting in peripheral blood allow for personalized TCR-based immunotherapies by Michael McDermott, Michael Martin, Hideho Okada, Joseph Costello, Michael Zhang, Tyler Borrman, Stefanie Mandl, Zheng Pan, Darwin Kwok, Chibo Hong, Cliff Wang, Nicholas Stevers, Benjamin Yuen, Songming Peng, Diana Nguyen, Stephanie Hilz, Joanna Phillips, Anny Shai, Nancy Ann Oberheim Bush, Shawn L Hervey-Jumper